Reduced funding puts HIV/AIDS care on edge

Data circulating about HIV indicates that 3.2 million Nigerians live with the virus

The country’s programme for HIV appears floating. For years, it has been largely run with funding from the U.S. president’s emergency plan for AIDS relief (PEPFAR). PEPFAR invested more than $5 billion as at 2017 to provide antiretroviral treatment for 880,668 people, testing for 7.76 million, care and support for 1.28 million orphans, vulnerable children and their caregivers.

But total funding from PEPFAR dropped from $409.1m in 2016 to $383.6m in 2017. The gain for the programme is a loss for close to a million said to be on treatment across nearly 4,000 facilities that provide services.

“What’s changed is that we are suffering the way we used to suffer,” said Omosehin, the national coordinator of the Network of People Living with HIV/AIDS.

“Responsibility for commodities and logistics at facilities providing services, some of those things we used to depend on has been shifted to the patient. All of these unnecessary charges are barriers to treatment,” he said.

Tests for viral load, CD4 count, blood count costs anything between N2,000 and N3,000 each and some centres tag on N1,000 every month as patients pick up their drugs, with patients racking up N12,000 for drug pickup at the end of the year.

Bills of N500 and N1,000 might be considered affordable but many people living with HIV have already seen their finances battered.

“And when you look at the economic situation of the country, even those who are negative are unemployed. How much can we cry as persons living with HIV if the people who are negative don’t even have, not to talk of those of us living with HIV,” said Omosehin.

Some facilities demand payment for every chemistry and hematology evaluation and tests can be up to three times a year, depending on a doctor’s judgment, he added.

“For an individual who has Ebola, you can’t say they should come to pay for treatment. It is a public health concern. If that individual goes back home because of charges, because of even N50, he is going to transmit the infection to a whole lot of communities. The same thing is applicable to HIV. If we are going to put the epidemic under control we shouldn’t attach any charges.”

Reduced funding has hit treatment and prevention the most.

“The number of people on treatment is directly related to unit cost of treatment, which is about procurement of drugs and provision of services,” said Kayode Ogungbemi, an assistant director at the National Agency for Control of AIDS.

“Reduction in donor funding can also be a blessing. It is a wake-up call for the country to ensure that we increase domestic funding, and that has picked up in the last two, three years. When we depended on donors, we went to sleep.”

The National Treatment Progamme supports treatment centres in Abia and Taraba and commits to add 50,000 more patients on the list. It also plans to scale up to six states plus the FCT.

“This is as a result of the threat we are getting from reduction in donor funding. That’s why I say it is a blessing in disguise. We think we can continue to put pressure on federal government to increase domestic funding,” said Ogungbemi.

PEPFAR’s uncertainty also raised questions on data: exactly what is the prevalence of HIV in Nigeria. This June, it joined the federal government to launch an AIDS indicator and impact survey. It turns out much of prevalence data from sentinel sites, mainly involving women visiting hospitals for antenatal services, and excluding men and young people who have no business there.

“If the data has been wrong all this time, that means the survey is going to be a game changer,” said Ifeanyi Nsofor, the health policy advisor at Nigeria Health Watch and chief executive officer at EpiAfric.

“We say prevalence is 3.4%. What if it is actually 1.5%. That means we know the exact burden, we know what is needed to address it and going forward HIV programme becomes based on evidence, not data that’s been distorted all this while.”

Preliminary results show likely less prevalence and incidence, and full results expected next year could change the narrative on HIV burden and coverage so far. It should also call for Nigeria to take more leadership, and even model its drug procurement on South Africa’s “bulk purchase” model, according to Nsofor.

For the last 10 years, Nigeria has contributed the highest number of HIV deaths-up to 200,000 people in 2016.

“Against the back drop of media reports, I wish to state that there is no crack in APC caucus of the House. We have internal issues and there is nothing unusual about it. However, these issues will be resolved internally. We have one caucus and @femigbaja is the leader. Thank you.” - Kano House of Representatives member and leader of the Parliamentary Support Group, Abdulmumin Jibrin.

“What we need to do as politicians and as people representing those who elected us is to always put the country first and know very well that we have both constitutional and moral duty to work for the progress of Nigeria and of this government.” - Shehu Sani, the Senator representing Kaduna Central in the National Assembly.